Shoulder Innovations SI

What to see in Shoulder Innovations now

Is Wall Street adding or cutting?+14

72 13F filers hold it · +14 against the quarter before · shares held +8.6%

Holdings of 06/30

Who bought more than 5%?10.7%

Gilde Healthcare Holding B.V. holds 10.7% · −1.1pp on the report before

Filed 08/07

Is stock about to come to market?$187.7K

$187.7K of planned sales filed in 30 days · under 0.1% of the units outstanding

Filed 09/14

$187.7K of planned sales filed in 30 days · under 0.1% of the units outstandingFiled 09/14

	Trade type
Matthew Fraser AhearnChief Operating Officer	Open-market sale10b5-1 plan	06/15	06/16	1,644 sh	$18.20	$29,920.8	−0.6%
Matthew Fraser AhearnChief Operating Officer	Open-market sale10b5-1 plan	06/15	06/16	2,500 sh	$19.26	$48,150	−0.9%
Matthew Fraser AhearnChief Operating Officer	Open-market sale10b5-1 plan	06/12	06/16	15,856 sh	$18.68	$296,190.08	−5.5%
Richard BuchholzDirector	Open-market buy	03/13	03/17	1,000 sh	$14.84	$14,840	+7.9%
Robert Joseph BallCEO & Executive Chairman	Open-market buy	03/13	03/17	2,200 sh	$15.18	$33,396	+0.8%


Robert Joseph BallOfficer, Director	Shoulder InnovationsSI	10,175 sh	$187,706.37	09/14	Filed 09/14
Matthew Fraser AhearnDirector, Officer	Shoulder InnovationsSI10b5-1 plan	22,500 sh	$466,425	08/17	Filed 08/17
Gilde Healthcare Holding B.V.10% Stockholder	Shoulder InnovationsSI	200,000 sh	$4,850,000	07/29	Filed 07/29
Matthew Fraser AhearnDirector, Officer	Shoulder InnovationsSI10b5-1 plan	20,000 sh	$375,200	06/12	Filed 06/12